APO Research
Talk to an analyst

APO RESEARCH · REPORT

E-Prescribing (eRx) Platform

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global E-Prescribing (eRx) Platform Market Analysis and Forecast 2026-2032

12 August 2026188 pages

Choose your research edition.

Industry ResearchE-Prescribing (eRx) Platform Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal E-Prescribing (eRx) Platform Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal E-Prescribing (eRx) Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal E-Prescribing (eRx) Platform Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal E-Prescribing (eRx) Platform Market Analysis and Forecast 2026-2032188 pages · $4,950 USD

Market perspective

The global E-Prescribing (eRx) Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for E-Prescribing (eRx) Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for E-Prescribing (eRx) Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for E-Prescribing (eRx) Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for E-Prescribing (eRx) Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of E-Prescribing (eRx) Platform include MediRecords, RxSure, DrFirst, DoseSpot, Veradigm (Allscripts), Practice Fusion, Chetu, Ensora (formerly NewCrop) and Qualifacts, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for E-Prescribing (eRx) Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of E-Prescribing (eRx) Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for E-Prescribing (eRx) Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the E-Prescribing (eRx) Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global E-Prescribing (eRx) Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for E-Prescribing (eRx) Platform revenue, projected growth trends, production technology, application and end-user industry.

E-Prescribing (eRx) Platform Segment by Company

MediRecords

RxSure

DrFirst

DoseSpot

Veradigm (Allscripts)

Practice Fusion

Chetu

Ensora (formerly NewCrop)

Qualifacts

H2H Solutions

Oracle Health

Optum

DAW (ScriptSure)

Tebra

EverHealth (DrChrono)

Surescripts

RXNT

iPrescribe

E-Prescribing (eRx) Platform Segment by Type

Cloud-based

On-premise

E-Prescribing (eRx) Platform Segment by Application

Physician Practice eRx

Health System eRx

Dental and Behavioral Health eRx

Telehealth eRx

Long-term Care eRx

E-Prescribing (eRx) Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global E-Prescribing (eRx) Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of E-Prescribing (eRx) Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of E-Prescribing (eRx) Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of E-Prescribing (eRx) Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of E-Prescribing (eRx) Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, E-Prescribing (eRx) Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global E-Prescribing (eRx) Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-based Major Player Table 3. On-premise Major Player Table 4. Global E-Prescribing (eRx) Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Physician Practice eRx Major Player Table 6. Health System eRx Major Player Table 7. Dental and Behavioral Health eRx Major Player Table 8. Telehealth eRx Major Player Table 9. Long-term Care eRx Major Player Table 10. E-Prescribing (eRx) Platform Industry Trends Table 11. E-Prescribing (eRx) Platform Industry Drivers Table 12. E-Prescribing (eRx) Platform Industry Opportunities and Challenges Table 13. E-Prescribing (eRx) Platform Industry Restraints Table 14. Global E-Prescribing (eRx) Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global E-Prescribing (eRx) Platform Market Size by Region (2021-2026) & (US$ Million) Table 16. Global E-Prescribing (eRx) Platform Market Share by Region (2021-2026) Table 17. Global E-Prescribing (eRx) Platform Market Size by Region (2027-2032) & (US$ Million) Table 18. Global E-Prescribing (eRx) Platform Market Share by Region (2027-2032) Table 19. Global E-Prescribing (eRx) Platform Revenue by Players (US$ Million) & (2021-2026) Table 20. Global E-Prescribing (eRx) Platform Revenue Market Share by Players (2021-2026) Table 21. Global E-Prescribing (eRx) Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global E-Prescribing (eRx) Platform Key Players Headquarters & Area Served Table 23. Global E-Prescribing (eRx) Platform Players, Product Type & Application Table 24. Global E-Prescribing (eRx) Platform Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global E-Prescribing (eRx) Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global E-Prescribing (eRx) Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global E-Prescribing (eRx) Platform Revenue by Type (2021-2026) & (US$ Million) Table 29. Global E-Prescribing (eRx) Platform Revenue by Type (2027-2032) & (US$ Million) Table 30. Global E-Prescribing (eRx) Platform Revenue Market Share by Type (2021-2026) Table 31. Global E-Prescribing (eRx) Platform Revenue Market Share by Type (2027-2032) Table 32. Global E-Prescribing (eRx) Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global E-Prescribing (eRx) Platform Revenue by Application (2021-2026) & (US$ Million) Table 34. Global E-Prescribing (eRx) Platform Revenue by Application (2027-2032) & (US$ Million) Table 35. Global E-Prescribing (eRx) Platform Revenue Market Share by Application (2021-2026) Table 36. Global E-Prescribing (eRx) Platform Revenue Market Share by Application (2027-2032) Table 37. MediRecords Company Information Table 38. MediRecords Business Overview Table 39. MediRecords E-Prescribing (eRx) Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. MediRecords E-Prescribing (eRx) Platform Product Portfolio Table 41. MediRecords Recent Development Table 42. RxSure Company Information Table 43. RxSure Business Overview Table 44. RxSure E-Prescribing (eRx) Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. RxSure E-Prescribing (eRx) Platform Product Portfolio Table 46. RxSure Recent Development Table 47. DrFirst Company Information Table 48. DrFirst Business Overview Table 49. DrFirst E-Prescribing (eRx) Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. DrFirst E-Prescribing (eRx) Platform Product Portfolio Table 51. DrFirst Recent Development Table 52. DoseSpot Company Information Table 53. DoseSpot Business Overview Table 54. DoseSpot E-Prescribing (eRx) Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. DoseSpot E-Prescribing (eRx) Platform Product Portfolio Table 56. DoseSpot Recent Development Table 57. Veradigm (Allscripts) Company Information Table 58. Veradigm (Allscripts) Business Overview Table 59. Veradigm (Allscripts) E-Prescribing (eRx) Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Veradigm (Allscripts) E-Prescribing (eRx) Platform Product Portfolio Table 61. Veradigm (Allscripts) Recent Development Table 62. Practice Fusion Company Information Table 63. Practice Fusion Business Overview Table 64. Practice Fusion E-Prescribing (eRx) Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Practice Fusion E-Prescribing (eRx) Platform Product Portfolio Table 66. Practice Fusion Recent Development Table 67. Chetu Company Information Table 68. Chetu Business Overview Table 69. Chetu E-Prescribing (eRx) Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Chetu E-Prescribing (eRx) Platform Product Portfolio Table 71. Chetu Recent Development Table 72. Ensora (formerly NewCrop) Company Information Table 73. Ensora (formerly NewCrop) Business Overview Table 74. Ensora (formerly NewCrop) E-Prescribing (eRx) Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Ensora (formerly NewCrop) E-Prescribing (eRx) Platform Product Portfolio Table 76. Ensora (formerly NewCrop) Recent Development Table 77. Qualifacts Company Information Table 78. Qualifacts Business Overview Table 79. Qualifacts E-Prescribing (eRx) Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Qualifacts E-Prescribing (eRx) Platform Product Portfolio Table 81. Qualifacts Recent Development Table 82. H2H Solutions Company Information Table 83. H2H Solutions Business Overview Table 84. H2H Solutions E-Prescribing (eRx) Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. H2H Solutions E-Prescribing (eRx) Platform Product Portfolio Table 86. H2H Solutions Recent Development Table 87. Oracle Health Company Information Table 88. Oracle Health Business Overview Table 89. Oracle Health E-Prescribing (eRx) Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Oracle Health E-Prescribing (eRx) Platform Product Portfolio Table 91. Oracle Health Recent Development Table 92. Optum Company Information Table 93. Optum Business Overview Table 94. Optum E-Prescribing (eRx) Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Optum E-Prescribing (eRx) Platform Product Portfolio Table 96. Optum Recent Development Table 97. DAW (ScriptSure) Company Information Table 98. DAW (ScriptSure) Business Overview Table 99. DAW (ScriptSure) E-Prescribing (eRx) Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. DAW (ScriptSure) E-Prescribing (eRx) Platform Product Portfolio Table 101. DAW (ScriptSure) Recent Development Table 102. Tebra Company Information Table 103. Tebra Business Overview Table 104. Tebra E-Prescribing (eRx) Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Tebra E-Prescribing (eRx) Platform Product Portfolio Table 106. Tebra Recent Development Table 107. EverHealth (DrChrono) Company Information Table 108. EverHealth (DrChrono) Business Overview Table 109. EverHealth (DrChrono) E-Prescribing (eRx) Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. EverHealth (DrChrono) E-Prescribing (eRx) Platform Product Portfolio Table 111. EverHealth (DrChrono) Recent Development Table 112. Surescripts Company Information Table 113. Surescripts Business Overview Table 114. Surescripts E-Prescribing (eRx) Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Surescripts E-Prescribing (eRx) Platform Product Portfolio Table 116. Surescripts Recent Development Table 117. RXNT Company Information Table 118. RXNT Business Overview Table 119. RXNT E-Prescribing (eRx) Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. RXNT E-Prescribing (eRx) Platform Product Portfolio Table 121. RXNT Recent Development Table 122. iPrescribe Company Information Table 123. iPrescribe Business Overview Table 124. iPrescribe E-Prescribing (eRx) Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. iPrescribe E-Prescribing (eRx) Platform Product Portfolio Table 126. iPrescribe Recent Development Table 127. North America E-Prescribing (eRx) Platform Revenue by Type (2021-2026) & (US$ Million) Table 128. North America E-Prescribing (eRx) Platform Revenue by Type (2027-2032) & (US$ Million) Table 129. North America E-Prescribing (eRx) Platform Revenue by Application (2021-2026) & (US$ Million) Table 130. North America E-Prescribing (eRx) Platform Revenue by Application (2027-2032) & (US$ Million) Table 131. North America E-Prescribing (eRx) Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America E-Prescribing (eRx) Platform Revenue by Country (2021-2026) & (US$ Million) Table 133. North America E-Prescribing (eRx) Platform Revenue by Country (US$ Million) & (2027-2032) Table 134. Europe E-Prescribing (eRx) Platform Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe E-Prescribing (eRx) Platform Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe E-Prescribing (eRx) Platform Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe E-Prescribing (eRx) Platform Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe E-Prescribing (eRx) Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe E-Prescribing (eRx) Platform Revenue by Country (2021-2026) & (US$ Million) Table 140. Europe E-Prescribing (eRx) Platform Revenue by Country (US$ Million) & (2027-2032) Table 141. China E-Prescribing (eRx) Platform Revenue by Type (2021-2026) & (US$ Million) Table 142. China E-Prescribing (eRx) Platform Revenue by Type (2027-2032) & (US$ Million) Table 143. China E-Prescribing (eRx) Platform Revenue by Application (2021-2026) & (US$ Million) Table 144. China E-Prescribing (eRx) Platform Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia E-Prescribing (eRx) Platform Revenue by Type (2021-2026) & (US$ Million) Table 146. Asia E-Prescribing (eRx) Platform Revenue by Type (2027-2032) & (US$ Million) Table 147. Asia E-Prescribing (eRx) Platform Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia E-Prescribing (eRx) Platform Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia E-Prescribing (eRx) Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia E-Prescribing (eRx) Platform Revenue by Region (US$ Million) & (2021-2026) Table 151. Asia E-Prescribing (eRx) Platform Revenue by Region (US$ Million) & (2027-2032) Table 152. SAMEA E-Prescribing (eRx) Platform Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA E-Prescribing (eRx) Platform Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA E-Prescribing (eRx) Platform Revenue by Application (2021-2026) & (US$ Million) Table 155. SAMEA E-Prescribing (eRx) Platform Revenue by Application (2027-2032) & (US$ Million) Table 156. SAMEA E-Prescribing (eRx) Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. SAMEA E-Prescribing (eRx) Platform Revenue by Country (2021-2026) & (US$ Million) Table 158. SAMEA E-Prescribing (eRx) Platform Revenue by Country (US$ Million) & (2027-2032) Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. E-Prescribing (eRx) Platform Image Figure 2. Global E-Prescribing (eRx) Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global E-Prescribing (eRx) Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-premise Image Figure 6. Global E-Prescribing (eRx) Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global E-Prescribing (eRx) Platform Market Size Share 2021 VS 2025 VS 2032 Figure 8. Physician Practice eRx Image Figure 9. Health System eRx Image Figure 10. Dental and Behavioral Health eRx Image Figure 11. Telehealth eRx Image Figure 12. Long-term Care eRx Image Figure 13. Global E-Prescribing (eRx) Platform Market Size (US$ Million) & (2021-2032) Figure 14. Global E-Prescribing (eRx) Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global E-Prescribing (eRx) Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global E-Prescribing (eRx) Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global E-Prescribing (eRx) Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global E-Prescribing (eRx) Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global E-Prescribing (eRx) Platform Revenue Market Share by Type (2021-2032) Figure 21. Global E-Prescribing (eRx) Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global E-Prescribing (eRx) Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global E-Prescribing (eRx) Platform Revenue Market Share by Application (2021-2032) Figure 24. North America E-Prescribing (eRx) Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America E-Prescribing (eRx) Platform Revenue Share by Type (2021-2032) Figure 26. North America E-Prescribing (eRx) Platform Revenue Share by Application (2021-2032) Figure 27. North America E-Prescribing (eRx) Platform Revenue Share by Country (2021-2032) Figure 28. United States E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe E-Prescribing (eRx) Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe E-Prescribing (eRx) Platform Revenue Share by Type (2021-2032) Figure 33. Europe E-Prescribing (eRx) Platform Revenue Share by Application (2021-2032) Figure 34. Europe E-Prescribing (eRx) Platform Revenue Share by Country (2021-2032) Figure 35. Germany E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China E-Prescribing (eRx) Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China E-Prescribing (eRx) Platform Revenue Share by Type (2021-2032) Figure 45. China E-Prescribing (eRx) Platform Revenue Share by Application (2021-2032) Figure 46. Asia E-Prescribing (eRx) Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia E-Prescribing (eRx) Platform Revenue Share by Type (2021-2032) Figure 48. Asia E-Prescribing (eRx) Platform Revenue Share by Application (2021-2032) Figure 49. Asia E-Prescribing (eRx) Platform Revenue Share by Region (2021-2032) Figure 50. Japan E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA E-Prescribing (eRx) Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA E-Prescribing (eRx) Platform Revenue Share by Type (2021-2032) Figure 58. SAMEA E-Prescribing (eRx) Platform Revenue Share by Application (2021-2032) Figure 59. SAMEA E-Prescribing (eRx) Platform Revenue Share by Country (2021-2032) Figure 60. Brazil E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt E-Prescribing (eRx) Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Physician Practice eRx
  • Health System eRx
  • Dental and Behavioral Health eRx
  • Telehealth eRx
  • Long-term Care eRx
Companies covered
  • MediRecords
  • RxSure
  • DrFirst
  • DoseSpot
  • Veradigm (Allscripts)
  • Practice Fusion
  • Chetu
  • Ensora (formerly NewCrop)
  • Qualifacts
  • H2H Solutions
  • Oracle Health
  • Optum
  • DAW (ScriptSure)
  • Tebra
  • EverHealth (DrChrono)
  • Surescripts
  • RXNT
  • iPrescribe

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 E-Prescribing (eRx) Platform Market by Type
  3. 1.2.1 Global E-Prescribing (eRx) Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-premise
  6. 1.3 E-Prescribing (eRx) Platform Market by Application
  7. 1.3.1 Global E-Prescribing (eRx) Platform Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Physician Practice eRx
  9. 1.3.3 Health System eRx
  10. 1.3.4 Dental and Behavioral Health eRx
  11. 1.3.5 Telehealth eRx
  12. 1.3.6 Long-term Care eRx
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 E-Prescribing (eRx) Platform Market Dynamics
  1. 2.1 E-Prescribing (eRx) Platform Industry Trends
  2. 2.2 E-Prescribing (eRx) Platform Industry Drivers
  3. 2.3 E-Prescribing (eRx) Platform Industry Opportunities and Challenges
  4. 2.4 E-Prescribing (eRx) Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global E-Prescribing (eRx) Platform Market Perspective (2021-2032)
  2. 3.2 Global E-Prescribing (eRx) Platform Growth Trends by Region
  3. 3.2.1 Global E-Prescribing (eRx) Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global E-Prescribing (eRx) Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global E-Prescribing (eRx) Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global E-Prescribing (eRx) Platform Revenue by Players
  2. 4.1.1 Global E-Prescribing (eRx) Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global E-Prescribing (eRx) Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global E-Prescribing (eRx) Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global E-Prescribing (eRx) Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global E-Prescribing (eRx) Platform Key Players Headquarters & Area Served
  7. 4.4 Global E-Prescribing (eRx) Platform Players, Product Type & Application
  8. 4.5 Global E-Prescribing (eRx) Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global E-Prescribing (eRx) Platform Market CR5 and HHI
  11. 4.6.3 2025 E-Prescribing (eRx) Platform Tier 1, Tier 2, and Tier 3
5 E-Prescribing (eRx) Platform Market Size by Type
  1. 5.1 Global E-Prescribing (eRx) Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global E-Prescribing (eRx) Platform Revenue by Type (2021-2032)
  3. 5.3 Global E-Prescribing (eRx) Platform Revenue Market Share by Type (2021-2032)
6 E-Prescribing (eRx) Platform Market Size by Application
  1. 6.1 Global E-Prescribing (eRx) Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global E-Prescribing (eRx) Platform Revenue by Application (2021-2032)
  3. 6.3 Global E-Prescribing (eRx) Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 MediRecords
  2. 7.1.1 MediRecords Company Information
  3. 7.1.2 MediRecords Business Overview
  4. 7.1.3 MediRecords E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 MediRecords E-Prescribing (eRx) Platform Product Portfolio
  6. 7.1.5 MediRecords Recent Developments
  7. 7.2 RxSure
  8. 7.2.1 RxSure Company Information
  9. 7.2.2 RxSure Business Overview
  10. 7.2.3 RxSure E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 RxSure E-Prescribing (eRx) Platform Product Portfolio
  12. 7.2.5 RxSure Recent Developments
  13. 7.3 DrFirst
  14. 7.3.1 DrFirst Company Information
  15. 7.3.2 DrFirst Business Overview
  16. 7.3.3 DrFirst E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 DrFirst E-Prescribing (eRx) Platform Product Portfolio
  18. 7.3.5 DrFirst Recent Developments
  19. 7.4 DoseSpot
  20. 7.4.1 DoseSpot Company Information
  21. 7.4.2 DoseSpot Business Overview
  22. 7.4.3 DoseSpot E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 DoseSpot E-Prescribing (eRx) Platform Product Portfolio
  24. 7.4.5 DoseSpot Recent Developments
  25. 7.5 Veradigm (Allscripts)
  26. 7.5.1 Veradigm (Allscripts) Company Information
  27. 7.5.2 Veradigm (Allscripts) Business Overview
  28. 7.5.3 Veradigm (Allscripts) E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Veradigm (Allscripts) E-Prescribing (eRx) Platform Product Portfolio
  30. 7.5.5 Veradigm (Allscripts) Recent Developments
  31. 7.6 Practice Fusion
  32. 7.6.1 Practice Fusion Company Information
  33. 7.6.2 Practice Fusion Business Overview
  34. 7.6.3 Practice Fusion E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Practice Fusion E-Prescribing (eRx) Platform Product Portfolio
  36. 7.6.5 Practice Fusion Recent Developments
  37. 7.7 Chetu
  38. 7.7.1 Chetu Company Information
  39. 7.7.2 Chetu Business Overview
  40. 7.7.3 Chetu E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Chetu E-Prescribing (eRx) Platform Product Portfolio
  42. 7.7.5 Chetu Recent Developments
  43. 7.8 Ensora (formerly NewCrop)
  44. 7.8.1 Ensora (formerly NewCrop) Company Information
  45. 7.8.2 Ensora (formerly NewCrop) Business Overview
  46. 7.8.3 Ensora (formerly NewCrop) E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Ensora (formerly NewCrop) E-Prescribing (eRx) Platform Product Portfolio
  48. 7.8.5 Ensora (formerly NewCrop) Recent Developments
  49. 7.9 Qualifacts
  50. 7.9.1 Qualifacts Company Information
  51. 7.9.2 Qualifacts Business Overview
  52. 7.9.3 Qualifacts E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Qualifacts E-Prescribing (eRx) Platform Product Portfolio
  54. 7.9.5 Qualifacts Recent Developments
  55. 7.10 H2H Solutions
  56. 7.10.1 H2H Solutions Company Information
  57. 7.10.2 H2H Solutions Business Overview
  58. 7.10.3 H2H Solutions E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 H2H Solutions E-Prescribing (eRx) Platform Product Portfolio
  60. 7.10.5 H2H Solutions Recent Developments
  61. 7.11 Oracle Health
  62. 7.11.1 Oracle Health Company Information
  63. 7.11.2 Oracle Health Business Overview
  64. 7.11.3 Oracle Health E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Oracle Health E-Prescribing (eRx) Platform Product Portfolio
  66. 7.11.5 Oracle Health Recent Developments
  67. 7.12 Optum
  68. 7.12.1 Optum Company Information
  69. 7.12.2 Optum Business Overview
  70. 7.12.3 Optum E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Optum E-Prescribing (eRx) Platform Product Portfolio
  72. 7.12.5 Optum Recent Developments
  73. 7.13 DAW (ScriptSure)
  74. 7.13.1 DAW (ScriptSure) Company Information
  75. 7.13.2 DAW (ScriptSure) Business Overview
  76. 7.13.3 DAW (ScriptSure) E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  77. 7.13.4 DAW (ScriptSure) E-Prescribing (eRx) Platform Product Portfolio
  78. 7.13.5 DAW (ScriptSure) Recent Developments
  79. 7.14 Tebra
  80. 7.14.1 Tebra Company Information
  81. 7.14.2 Tebra Business Overview
  82. 7.14.3 Tebra E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Tebra E-Prescribing (eRx) Platform Product Portfolio
  84. 7.14.5 Tebra Recent Developments
  85. 7.15 EverHealth (DrChrono)
  86. 7.15.1 EverHealth (DrChrono) Company Information
  87. 7.15.2 EverHealth (DrChrono) Business Overview
  88. 7.15.3 EverHealth (DrChrono) E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  89. 7.15.4 EverHealth (DrChrono) E-Prescribing (eRx) Platform Product Portfolio
  90. 7.15.5 EverHealth (DrChrono) Recent Developments
  91. 7.16 Surescripts
  92. 7.16.1 Surescripts Company Information
  93. 7.16.2 Surescripts Business Overview
  94. 7.16.3 Surescripts E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Surescripts E-Prescribing (eRx) Platform Product Portfolio
  96. 7.16.5 Surescripts Recent Developments
  97. 7.17 RXNT
  98. 7.17.1 RXNT Company Information
  99. 7.17.2 RXNT Business Overview
  100. 7.17.3 RXNT E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  101. 7.17.4 RXNT E-Prescribing (eRx) Platform Product Portfolio
  102. 7.17.5 RXNT Recent Developments
  103. 7.18 iPrescribe
  104. 7.18.1 iPrescribe Company Information
  105. 7.18.2 iPrescribe Business Overview
  106. 7.18.3 iPrescribe E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  107. 7.18.4 iPrescribe E-Prescribing (eRx) Platform Product Portfolio
  108. 7.18.5 iPrescribe Recent Developments
8 North America
  1. 8.1 North America E-Prescribing (eRx) Platform Revenue (2021-2032)
  2. 8.2 North America E-Prescribing (eRx) Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America E-Prescribing (eRx) Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America E-Prescribing (eRx) Platform Revenue by Type (2027-2032)
  5. 8.3 North America E-Prescribing (eRx) Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America E-Prescribing (eRx) Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America E-Prescribing (eRx) Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America E-Prescribing (eRx) Platform Revenue by Application (2027-2032)
  9. 8.5 North America E-Prescribing (eRx) Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America E-Prescribing (eRx) Platform Revenue by Country
  11. 8.6.1 North America E-Prescribing (eRx) Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America E-Prescribing (eRx) Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America E-Prescribing (eRx) Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe E-Prescribing (eRx) Platform Revenue (2021-2032)
  2. 9.2 Europe E-Prescribing (eRx) Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe E-Prescribing (eRx) Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe E-Prescribing (eRx) Platform Revenue by Type (2027-2032)
  5. 9.3 Europe E-Prescribing (eRx) Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe E-Prescribing (eRx) Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe E-Prescribing (eRx) Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe E-Prescribing (eRx) Platform Revenue by Application (2027-2032)
  9. 9.5 Europe E-Prescribing (eRx) Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe E-Prescribing (eRx) Platform Revenue by Country
  11. 9.6.1 Europe E-Prescribing (eRx) Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe E-Prescribing (eRx) Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe E-Prescribing (eRx) Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China E-Prescribing (eRx) Platform Revenue (2021-2032)
  2. 10.2 China E-Prescribing (eRx) Platform Revenue by Type (2021-2032)
  3. 10.2.1 China E-Prescribing (eRx) Platform Revenue by Type (2021-2026)
  4. 10.2.2 China E-Prescribing (eRx) Platform Revenue by Type (2027-2032)
  5. 10.3 China E-Prescribing (eRx) Platform Revenue Share by Type (2021-2032)
  6. 10.4 China E-Prescribing (eRx) Platform Revenue by Application (2021-2032)
  7. 10.4.1 China E-Prescribing (eRx) Platform Revenue by Application (2021-2026)
  8. 10.4.2 China E-Prescribing (eRx) Platform Revenue by Application (2027-2032)
  9. 10.5 China E-Prescribing (eRx) Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia E-Prescribing (eRx) Platform Revenue (2021-2032)
  2. 11.2 Asia E-Prescribing (eRx) Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia E-Prescribing (eRx) Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia E-Prescribing (eRx) Platform Revenue by Type (2027-2032)
  5. 11.3 Asia E-Prescribing (eRx) Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia E-Prescribing (eRx) Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia E-Prescribing (eRx) Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia E-Prescribing (eRx) Platform Revenue by Application (2027-2032)
  9. 11.5 Asia E-Prescribing (eRx) Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia E-Prescribing (eRx) Platform Revenue by Country
  11. 11.6.1 Asia E-Prescribing (eRx) Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia E-Prescribing (eRx) Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia E-Prescribing (eRx) Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA E-Prescribing (eRx) Platform Revenue (2021-2032)
  2. 12.2 SAMEA E-Prescribing (eRx) Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA E-Prescribing (eRx) Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA E-Prescribing (eRx) Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA E-Prescribing (eRx) Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA E-Prescribing (eRx) Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA E-Prescribing (eRx) Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA E-Prescribing (eRx) Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA E-Prescribing (eRx) Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA E-Prescribing (eRx) Platform Revenue by Country
  11. 12.6.1 SAMEA E-Prescribing (eRx) Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA E-Prescribing (eRx) Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA E-Prescribing (eRx) Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst